Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin

Journal of Hepatology

Volumn 27, Issue 2, 1997, Pages 358-362

  Cauza, Edmund ^a   Maier Dobersberger, Theresia ^a   Polli, Claudia ^a   Kaserer, Klaus ^a   Kramer, Ludwig ^a   Ferenci, Peter ^a  

^a NONE

Author keywords

Ceruloplasmin; Serum copper concentration; Wilson's disease

Indexed keywords

CERULOPLASMIN;

ARTICLE; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; COPPER BLOOD LEVEL; GENETIC SCREENING; HEPATITIS; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNODIFFUSION; LIVER BIOPSY; MALABSORPTION; PRIORITY JOURNAL; WILSON DISEASE;

EID: 0030873148     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80182-1     Document Type: Article

References (34)

1. Young F, Friedrichs WE, Cupples RL, Bonifacio MJ, Sanford JA, Horton WA. Human ceruloplasmin. J Biol Chem. 265:1990;10780-10785.
2. Ryden L, Eaker D. Identification of the thiol groups in human ceruloplasmin. Eur J Biochem. 132:1983;241-247.
3. Frieden E. Perspectives on copper biochemistry. Clin Physiol Biochem. 4:1986;11-19.
4. Gutteridge JM. Inhibition of the Fenton reaction by the protein caeruloplasmin and other copper complexes. Assessment of ferroxidase and radical scavenging activities. Chem Biol Interact. 56:1985;113-120.
5. Sternlieb J, Scheinberg IH. Ceruloplasmin in health and disease. Ann NY Acad Sci. 94:1961;71-76.
6. Barrow L, Tanner MS. Copper distribution among serum proteins in paediatric liver disorders and malignancies. Eur J Clin Invest. 18:1988;555-560.
7. Czaja MJ, Weiner FR, Schwarzenberg SJ, Sternlieb I, Scheinberg IH, Van Thiel DH, et al. Molecular studies of ceruloplasmin deficiency in Wilson's disease. J Clin Invest. 80:1987;1200-1204.
8. Perman JA, Werlin SL, Grand RJ, Watkin JB. Laboratory measure of copper metabolism in the differentiation of chronic active hepatitis and Wilson's disease in children. J Pediatr. 94:1979;564-568.
9. Walshe JM, Briggs J. Caeruloplasmin in liver disease. Lancet. ii:1962;263-265.
10. Stremmel W, Meyerrose KW, Neiderau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment and surival. Ann Intern Med. 115:1991;720-726.
11. Edward CQ, Williams DM, Cartwright GE. Hereditary hypoceruloplasminemia. Clin Gen. 15:1979;311-3116.
12. Sternlieb J. Perspectives on Wilson's disease. Hepatology. 12:1990;1234-1239.
13. Scheinberg IH, Sternlieb J. Wilson's disease. Smith LH. Major Problems in Internal Medicine. 23:1984;WB Saunders, Philadelphia.
14. Shaver WA, Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease. Hepatology. 6:1986;859-863.
15. Willson RA, Clayson KJ, Leon S. Unmeasurable serum alkaline phosphatase activity in Wilson's disease associated with fulminant hepatic failure and hemolysis. Hepatology. 7:1987;613-615.
16. Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson's disease in patients presenting with liver disease - a diagnostic challenge. Gastroenterology. 1997;. (in press).
17. Sallie R, Katsiyiannakis L, Balwin D, Davies S, O'Grady J, Mieli-Vergani G, et al. Failure of simple biochemical indices to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology. 16:1992;1206-1211.
18. Scheuer P. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 13:1992;372-374.
19. Kingston HM, Jassie LB. Microwave energy for acid decomposition at elevated temperatures and pressures using biological and botanical samples. Anal Chem. 58:1986;2534-2541.
20. Dati F, Lammers M, Adam A, Sondag D, Stienen L. Referenzwerte für 18 Plasmaproteine am Behring-Nephelometer-System. Lab Med. 13:1989;87-90.
21. Maier-Dobersberger T, Rack S, Granditsch G, Korninger L, Steindl P, Mannhalter C, et al. Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Gastroenterology. 109:1995;2015-2018.
22. Bachmann H, Lössner J, Kühn HJ, Siegemund R. Occurrence, genetics and epidemiology of Wilson's disease in east Germany. Czlonkowska A, van der Hamer CJA. Proc. 5th International Symposium on Wilson's disease. 1991;121-128 Technical University, Delft.
23. Walshe JM. Wilson's disease. Br Med J. 228:1984;2989.
24. Gibbs K, Walshe JM. A study of ceruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups. Q J Med. 48:1979;447-463.
25. Steindl P, Dienes HP, Dragosics B, Grimm G, Gangl A, Ferenci P. Correlation of serum ceruloplasmin with hepatic inflammation in Wilson's disease. (abstr.) Hepatology. 18:1993;277A.
26. Scott J, Gollan JL, Samourian S, Sherlock S. Wilson's disease, presenting as chronic active hepatitis. Gastroenterology. 74:1978;645-651.
27. German JL, Bearn AG. Effect of estrogen on copper metabolism in Wilson's disease. J Clin Invest. 40:1961;445-453.
28. Matsuda I, Pearson T, Holtzman NA. Determination of apoceruloplasmin by radioimmuno-assay in nutritional copper deficiency, Menkes' kinky hair syndrome, Wilson's disease, and umbilical cord blood. Pediatr Res. 8:1974;821-824.
29. Saenko EL, Skorobogat'ko OV, Yaropolov AI. Enzyme immunoassay (ELISA) determination of total ceruloplasmin in blood serum of patients with hepatocerebral dystrophy. Biochemistry USSR. 56:1991;1155-1159.
30. Mc Cullough AJ, Fleming CR, Thistle JL, Baldus WP, Ludwig J, McCall JT, et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology. 84:1983;161-167.
31. Scheinberg IH, Cook CD, Murphy JA. The concentration of copper and ceruloplasmin in maternal and infant plasma at delivery. J Clin Invest. 33:1954;963.
32. Lockey ME, Behar M, Viteri F, Scrimshaw NS. Value for copper, iron and iron binding capacity in the serum in kwashiorkor. Pediatrics. 22:1958;72-79.
33. Ilan Y, Hillman M, Oren R, Galun E, Shalit M. Undetectable ceruloplasmin values in a patient with autoimmune chronic active hepatitis. Gut. 32:1991;540-550.
34. Cox DW. Molecular advances in Wilson's disease. Progress in Liver Disease. X:1996;245-263. Chapter 10.